COMMUNIQUÉS West-GlobeNewswire
-
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
23/04/2024 - 13:00 -
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
23/04/2024 - 13:00 -
Regeneration Biomedical Doses First Patient in a First-in-Human Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brain of Patients with Alzheimer’s Disease
23/04/2024 - 13:00 -
Skye Bioscience to Present at Upcoming Investment Conferences
23/04/2024 - 13:00 -
CBDistillery™ shhh+ Distilled Deep Sleep Gummies Deliver Better Sleep, Improved Quality of Life
23/04/2024 - 13:00 -
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
23/04/2024 - 13:00 -
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
23/04/2024 - 13:00 -
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
23/04/2024 - 13:00 -
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
23/04/2024 - 13:00 -
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
23/04/2024 - 13:00 -
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
23/04/2024 - 13:00 -
CorVel Announces New Integrations for Managed Care Services Enabling Partners to Increase Connectivity and Create a Seamless Workflow Experience
23/04/2024 - 13:08 -
Sania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual Meeting
23/04/2024 - 13:27 -
KFSH&RC Announced as Strategic Partner for the Saudi American Healthcare Forum 2024
23/04/2024 - 13:29 -
Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024
23/04/2024 - 08:00 -
AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting
23/04/2024 - 08:00 -
Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 23 May 2024
23/04/2024 - 08:15 -
Curium Enrolls First Prostate Cancer Patients in its Phase 3 SOLAR Trials
23/04/2024 - 06:01 -
Communiqué de presse : L’étude de phase III LUNA 3 du rilzabrutinib pour le traitement de la thrombocytopénie immune a atteint son critère d’évaluation primaire
23/04/2024 - 07:00
Pages